Comprehensively assessing the clinical trial landscape in oncology over the last 10 years. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not include a full ...
Anlotinib in patients with recurrent platinum-resistant or refractory ovarian carcinoma: A prospective, single-arm, single-center, phase II clinical study. This is an ASCO Meeting Abstract from the ...